AI tokens
Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

Analysis of Operating Leases

Microsoft Excel

Adjustments to Financial Statements for Operating Leases

Amgen Inc., Financial Data: Reported vs. Adjusted

Amgen Inc., adjustments to financial statements

US$ in millions

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Adjustment to Total Assets
Total assets (as reported) 90,586 91,839 97,154 65,121 61,165
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1 — — — — —
Total assets (adjusted) 90,586 91,839 97,154 65,121 61,165
Adjustment to Total Debt
Total debt (as reported) 54,604 60,099 64,613 38,945 33,309
Add: Operating lease liability (before adoption of FASB Topic 842)2 — — — — —
Add: Current operating lease liabilities (included in Accrued liabilities) 135 107 119 156 145
Add: Noncurrent operating lease liabilities (included in Other noncurrent liabilities) 696 673 691 539 525
Total debt (adjusted) 55,435 60,879 65,423 39,640 33,979

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1, 2 Equal to total present value of future operating lease payments.


Adjusted Financial Ratios for Operating Leases (Summary)

Amgen Inc., Financial Ratios: Reported vs. Adjusted

Amgen Inc., adjusted financial ratios

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Total Asset Turnover1
Reported total asset turnover 0.39 0.35 0.28 0.38 0.40
Adjusted total asset turnover 0.39 0.35 0.28 0.38 0.40
Debt to Equity2
Reported debt to equity 6.31 10.23 10.37 10.64 4.97
Adjusted debt to equity 6.40 10.36 10.50 10.83 5.07
Return on Assets3 (ROA)
Reported ROA 8.51% 4.45% 6.91% 10.06% 9.63%
Adjusted ROA 8.51% 4.45% 6.91% 10.06% 9.63%

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

Financial ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Amgen Inc. adjusted total asset turnover ratio improved from 2023 to 2024 and from 2024 to 2025.
Adjusted debt to equity A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity. Amgen Inc. adjusted debt to equity ratio improved from 2023 to 2024 and from 2024 to 2025.
Adjusted ROA A profitability ratio calculated as net income divided by adjusted total assets. Amgen Inc. adjusted ROA deteriorated from 2023 to 2024 but then improved from 2024 to 2025 exceeding 2023 level.

Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Product sales 35,148 32,026 26,910 24,801 24,297
Total assets 90,586 91,839 97,154 65,121 61,165
Activity Ratio
Total asset turnover1 0.39 0.35 0.28 0.38 0.40
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Product sales 35,148 32,026 26,910 24,801 24,297
Adjusted total assets 90,586 91,839 97,154 65,121 61,165
Activity Ratio
Adjusted total asset turnover2 0.39 0.35 0.28 0.38 0.40

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 Total asset turnover = Product sales ÷ Total assets
= 35,148 ÷ 90,586 = 0.39

2 Adjusted total asset turnover = Product sales ÷ Adjusted total assets
= 35,148 ÷ 90,586 = 0.39

Activity ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Amgen Inc. adjusted total asset turnover ratio improved from 2023 to 2024 and from 2024 to 2025.

Adjusted Debt to Equity

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Total debt 54,604 60,099 64,613 38,945 33,309
Stockholders’ equity 8,658 5,877 6,232 3,661 6,700
Solvency Ratio
Debt to equity1 6.31 10.23 10.37 10.64 4.97
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Adjusted total debt 55,435 60,879 65,423 39,640 33,979
Stockholders’ equity 8,658 5,877 6,232 3,661 6,700
Solvency Ratio
Adjusted debt to equity2 6.40 10.36 10.50 10.83 5.07

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 Debt to equity = Total debt ÷ Stockholders’ equity
= 54,604 ÷ 8,658 = 6.31

2 Adjusted debt to equity = Adjusted total debt ÷ Stockholders’ equity
= 55,435 ÷ 8,658 = 6.40

Solvency ratio Description The company
Adjusted debt-to-equity A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity. Amgen Inc. adjusted debt-to-equity ratio improved from 2023 to 2024 and from 2024 to 2025.

Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Net income 7,711 4,090 6,717 6,552 5,893
Total assets 90,586 91,839 97,154 65,121 61,165
Profitability Ratio
ROA1 8.51% 4.45% 6.91% 10.06% 9.63%
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Net income 7,711 4,090 6,717 6,552 5,893
Adjusted total assets 90,586 91,839 97,154 65,121 61,165
Profitability Ratio
Adjusted ROA2 8.51% 4.45% 6.91% 10.06% 9.63%

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 ROA = 100 × Net income ÷ Total assets
= 100 × 7,711 ÷ 90,586 = 8.51%

2 Adjusted ROA = 100 × Net income ÷ Adjusted total assets
= 100 × 7,711 ÷ 90,586 = 8.51%

Profitability ratio Description The company
Adjusted ROA A profitability ratio calculated as net income divided by adjusted total assets. Amgen Inc. adjusted ROA deteriorated from 2023 to 2024 but then improved from 2024 to 2025 exceeding 2023 level.